Policy | April 01, 2024
Venus Remedies receives Rs. 2.50 crore under PLI scheme
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
These approvals mark significant progress for Venus Remedies in expanding its market presence
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)